X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs ORCHID PHARMA LTD - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD ORCHID PHARMA LTD MERCK LTD/
ORCHID PHARMA LTD
 
P/E (TTM) x 26.1 -0.8 - View Chart
P/BV x 2.9 0.6 523.2% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 MERCK LTD   ORCHID PHARMA LTD
EQUITY SHARE DATA
    MERCK LTD
Dec-16
ORCHID PHARMA LTD
Sep-13
MERCK LTD/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs1,060194 546.4%   
Low Rs62335 1,780.0%   
Sales per share (Unadj.) Rs632.4276.5 228.8%  
Earnings per share (Unadj.) Rs45.7-79.2 -57.7%  
Cash flow per share (Unadj.) Rs62.3-43.5 -143.4%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.853.9 720.9%  
Shares outstanding (eoy) m16.6070.45 23.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.30.4 321.3%   
Avg P/E ratio x18.4-1.4 -1,273.4%  
P/CF ratio (eoy) x13.5-2.6 -512.5%  
Price / Book Value ratio x2.22.1 101.9%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,9698,067 173.2%   
No. of employees `0001.62.8 56.5%   
Total wages/salary Rs m1,4872,527 58.8%   
Avg. sales/employee Rs Th6,631.96,956.1 95.3%   
Avg. wages/employee Rs Th939.2902.5 104.1%   
Avg. net profit/employee Rs Th479.4-1,993.0 -24.1%   
INCOME DATA
Net Sales Rs m10,49819,477 53.9%  
Other income Rs m242407 59.5%   
Total revenues Rs m10,74119,884 54.0%   
Gross profit Rs m1,1351,103 103.0%  
Depreciation Rs m2762,519 10.9%   
Interest Rs m05,227 0.0%   
Profit before tax Rs m1,102-6,236 -17.7%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m343-125 -274.2%   
Profit after tax Rs m759-5,580 -13.6%  
Gross profit margin %10.85.7 191.0%  
Effective tax rate %31.12.0 1,551.4%   
Net profit margin %7.2-28.7 -25.2%  
BALANCE SHEET DATA
Current assets Rs m6,41011,014 58.2%   
Current liabilities Rs m8,82832,060 27.5%   
Net working cap to sales %-23.0-108.1 21.3%  
Current ratio x0.70.3 211.3%  
Inventory Days Days5895 60.8%  
Debtors Days Days3834 114.4%  
Net fixed assets Rs m1,40629,440 4.8%   
Share capital Rs m166705 23.6%   
"Free" reserves Rs m6,2862,043 307.7%   
Net worth Rs m6,4553,800 169.9%   
Long term debt Rs m09,018 0.0%   
Total assets Rs m8,82846,510 19.0%  
Interest coverage xNM-0.2-  
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x1.20.4 284.0%   
Return on assets %8.6-0.8 -1,131.0%  
Return on equity %11.8-146.9 -8.0%  
Return on capital %17.1-3.7 -457.2%  
Exports to sales %8.337.9 21.9%   
Imports to sales %21.022.6 93.0%   
Exports (fob) Rs m8697,378 11.8%   
Imports (cif) Rs m2,2094,406 50.1%   
Fx inflow Rs m9597,513 12.8%   
Fx outflow Rs m2,6125,649 46.2%   
Net fx Rs m-1,6531,865 -88.7%   
CASH FLOW
From Operations Rs m1,0701,682 63.6%  
From Investments Rs m-750-9,860 7.6%  
From Financial Activity Rs m-1506,644 -2.3%  
Net Cashflow Rs m171-1,535 -11.1%  

Share Holding

Indian Promoters % 0.0 32.3 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 4.6 395.7%  
FIIs % 1.0 3.3 30.3%  
ADR/GDR % 0.0 4.6 -  
Free float % 29.1 55.3 52.6%  
Shareholders   28,591 84,811 33.7%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  ALEMBIC PHARMA  ELDER PHARMA  

Compare MERCK LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Vishal Sikka's Infosys Exit, White House Shake up & Cues to Watch Out Today(Pre-Open)

Indian share markets ended lower on Friday but gained during the overall week. At the closing bell on Friday, BSE Sensex closed lower by 271 points and the NSE Nifty finished down 67 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS